GSK and Google Parent Forge $715 Million Bioelectronic Medicines Firm

By Ben Hirschler LONDON – GlaxoSmithKline and Google parent Alphabet’s life sciences unit are creating a new company focused on fighting diseases by targeting electrical signals in the body, jump-starting a novel field of medicine called bioelectronics. Verily Life Sciences – known as Google’s life sciences unit until last year – and Britain’s biggest drugmaker

[ Read More ]

GlaxoSmithKline Invests $360 Mln in U.K. Despite Brexit Vote

By Ben Hirschler LONDON, July 27 – GlaxoSmithKline plans 275 million pounds ($361 million) of new investments at three drug manufacturing sites in Britain, signalling its confidence in the country despite last month’s vote to leave the European Union. Britain’s biggest drugmaker, which had argued against Brexit before the referendum, believes the UK remains an

[ Read More ]

GSK Plans Graduated Approach to Drug Patents to Help Poor

LONDON, March 31 – GlaxoSmithKline said on Thursday it would adopt a graduated approach to patenting its medicines, depending on the wealth of different countries, in order to make drugs more affordable in the developing world. Britain’s biggest drugmaker will not file patents for its drugs in the world’s poorest states, leaving the way clear

[ Read More ]